Skip to content

The efficacy of combination uses of pre-serum gel containing sodium hyaluronate and sodium ascorbyl phosphate with subcutaneous injection of hyaluronic filler: A split-face pilot randomized controlled study.

The efficacy of combination uses of pre-serum gel containing sodium hyaluronate and sodium ascorbyl phosphate with subcutaneous injection of hyaluronic filler: A split-face pilot randomized controlled study.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210629001
Enrollment
20
Registered
2021-06-29
Start date
2020-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy sodium hyaluronate, sodium ascorbyl phosphate, hyaluronic filler

Interventions

Volunteers were injected with hyaluronic filler on both sides of the face. One side of face was treated with Eucerine hyaluron-filler first serum moisture booster apply bid after washing. Follow-up ef
Active Comparator Drug,Placebo Comparator Drug
Eucerine hyaluron-filler first serum moisture booster,Placebo

Sponsors

Galderma (Thailand)
Lead Sponsor
Merz Aesthetics (Thailand) ,Beiersdorf (Thailand)
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Thai healthy volunteers aged equal to or more than 20 years 2. Patients who can come to follow up

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant, lactating, and postpartum within 3 months 2. Patients with history of hyaluronic acid allergy 3. Patients with other skin diseases, or having infection at the area of face 4. Immunocompromised patients 5. Patients treated with laser, radiofrequency, and focus ultrasound on the face in the past 12 months 6. Patients treated with filler on the face in the past 12 months 7. Patients treated with chemical peeling, treatment with vitamin C in the past 1 month

Design outcomes

Primary

MeasureTime frame
skin hydration Baseline, 2 weeks, 1, 2, and 3 months after treatment. Corneometer

Secondary

MeasureTime frame
indentation and maximum depth of wrinkle Baseline, 2 weeks, 1, 2, and 3 months after treatment. Antera analysis,Skin roughness Baseline, 2 weeks, 1, 2, and 3 months after treatment. Antera analysis,Physician improvement scale Baseline, 2 weeks, 1, 2, and 3 months after treatment. 6 points scale,Safety Baseline, 2 weeks, 1, 2, and 3 months after treatment. Adverse event

Countries

Thailand

Contacts

Public ContactRungsima Wanitphakdeedecha

Faculty of Medicine Siriraj Hospital, Mahidol University

rungsima.wan@mahidol.ac.th66816406300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026